JAGLX - Janus Henderson Global Life Sciences T
Nasdaq - Nasdaq Delayed Price. Currency in USD
60.91
-0.27 (-0.44%)
At close: 8:00PM EDT
Stock chart is not supported by your current browser
| Previous Close | 61.18 |
| YTD Return | 20.10% |
| Expense Ratio (net) | 0.91% |
| Category | Health |
| Last Cap Gain | 0.00 |
| Morningstar Rating | ★★★★★ |
| Morningstar Risk Rating | Average |
| Sustainability Rating |
| Net Assets | 4.11B |
| Beta (3Y Monthly) | 1.03 |
| Yield | 0.23% |
| 5y Average Return | N/A |
| Holdings Turnover | 38.00% |
| Last Dividend | 0.15 |
| Average for Category | N/A |
| Inception Date | Dec 31, 1998 |
- Zacks•4 days ago
3 Healthcare Funds to Ride VC Funding Wave
U.S. healthcare has caught the fancy of American and foreign venture capitalists alike.
- Zacks•last month
Play a Robust Biotech Industry With These 3 Solid Funds
A burgeoning economy and steady influx of funds make conditions ripe for diversification and further strengthening of the capital base.
- Zacks•9 months ago
5 Healthcare Mutual Funds to Buy in 2018
Broadly encouraging economic conditions, favorable tax policies and a higher number of approvals from the FDA makes healthcare mutual funds a hotbed of money
- Zacks•11 months ago
5 Best-Performing Healthcare Mutual Funds in Q3
Broadly encouraging economic conditions, favorable policies and a higher number of approvals from the FDA makes healthcare mutual funds a hotbed of money.
